The United States continued to lead global trade in conventional armaments last year, according to a newly updated report from the Congressional Research Service, but overall trade declined from the year before.
“Worldwide weapons orders decreased in 2015. The total of $79.8 billion was a decrease from $89 billion in 2014. The United States’ worldwide weapons agreements values increased in value from $36.1 billion in 2014 to $40.2 billion in 2015. The U.S. market share increased greatly as well, from roughly 40.5% in 2014 to 50.3% in 2015. Although the United States retained its position as the leading arms supplying nation in the world, nearly all other major suppliers saw increases too.”
The CRS report is based on access to unclassified but unpublished government databases. As such, the 72-page document provides a uniquely informative view of the global arms trade. See Conventional Arms Transfers to Developing Nations, 2008-2015, December 19, 2016.
Other new and updated reports from the Congressional Research Service include the following.
Defense Acquisitions: How and Where DOD Spends Its Contracting Dollars, updated December 20, 2016
U.S. Foreign Aid to the Palestinians, updated December 16, 2016
Tribal Broadband: Status of Deployment and Federal Funding Programs, updated December 20, 2016
The Federal Food Safety System: A Primer, updated December 16, 2016
State Management of Federal Lands: Frequently Asked Questions, updated December 16, 2016
The FCC’s Rules and Policies Regarding Media Ownership, Attribution, and Ownership Diversity, updated December 16, 2016
Special Minimum Wages for Workers with Disabilities: Frequently Asked Questions, updated December 16, 2016
Discretionary Budget Authority by Subfunction: An Overview, updated December 16, 2016
Restrictions on Lobbying the Government: Current Policy and Proposed Changes, CRS Insight, December 15, 2016
U.S. Policy on Cuban Migrants: In Brief, December 16, 2016
The African Union (AU): Key Issues and U.S.-AU Relations, December 16, 2016
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.